Foundations in Continuing Education

The Dental Patient with Diabetes

Chapter Fourteen - Prevention and Treatment of DM


Chapter 1: Glucose Metabolism and Hormonal Regulation Review

Chapter 2: Diabetes Mellitus

Chapter 3: Diabetes Mellitus Type 1

Chapter 4: Diabetes Mellitus Type 2

Chapter 5: Gestational Diabetes Mellitus (GDM)

Chapter 6: Pre Diabetes: Impaired Glucose Homeostasis

Chapter 7: Other Specific Types of Diabetes

Chapter 8: Diagnosing Diabetes

Chapter 9: Diagnosis

Chapter 10: Glucose Monitoring

Chapter 11: Complications of Diabetes

Chapter 12: The Dental Patient with Diabetes

Chapter 13: Successful Intervention of Diabetic Emergencies

Introduction
Diet/Nutrition
Exercise
Pharmacological
Intervention

Administration
Method of Injection
Oral Hypoglycemic
Agents

Secretagogues
Biguanides (Metformin)
Thiazolidinediones
(Actos, Avandia)

Glucosidase Inhibitors
(Precose, Glyset)

Combination
Medications

Chapter 15: Diabetes Medications

Chapter 16: Conclusion

Glossary

Appendices

References

Post Examination

Exit to Menu





Oral Hypoglycemic Agents

When sufficient results cannot be obtained through diet and exercise regimens it may become necessary for Type 2 diabetics to take oral hypoglycemic agents aimed at lowering blood glucose levels (see Table 9).

The four major classifications of oral hypoglycemic agents, are secretagogues (sulfonylurea drugs, meglitinides and D-Phenylalanines) biguanides (Metformin), Thiazolidinediones (Actos and Avandia) and Glucosidase Inhibitors (Precose and Glyset) Secretagogues act by increasing pancreatic production of insulin. Metformin's main action is to reducing glucose production in the liver, the Thiazolidinediones decrease insulin resistance and the Glucosidase Inhibitors delay carbohydrate absorption. (48)

Continue on to Secretagogues